Cargando…
Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
Autores principales: | Shyu, Kou-Gi, Velusamy, Marappan, Hsia, Chih-Wei, Yang, Chih-Hao, Hsia, Chih-Hsuan, Chou, Duen-Suey, Jayakumar, Thanasekaran, Sheu, Joen-Rong, Li, Jiun-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559297/ https://www.ncbi.nlm.nih.gov/pubmed/31059013 http://dx.doi.org/10.3892/ijmm.2019.4177 |
Ejemplares similares
-
Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
por: Shyu, Kou-Gi, et al.
Publicado: (2018) -
New Therapeutic Agent against Arterial Thrombosis: An Iridium(III)-Derived Organometallic Compound
por: Hsia, Chih-Wei, et al.
Publicado: (2017) -
Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation
por: Shyu, Ren-Shi, et al.
Publicado: (2018) -
Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2–PKC–AKT Activation in Human Platelets
por: Hsia, Chih-Wei, et al.
Publicado: (2019) -
Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate
por: Hsia, Chih-Wei, et al.
Publicado: (2018)